Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Eisai discloses antitumor compounds

Nov. 15, 1996

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

HIV protease inhibitors described by DuPont

Nov. 15, 1996

Novel antibacterial compound from Banyu

Nov. 15, 1996

New NK1 antagonists claimed by Takeda

Nov. 15, 1996

Anti-H. pylori antisense oligonucleotides reported by SCRAS

Nov. 8, 1996

Daiichi discloses CCK-B/gastrin receptor antagonists

Nov. 8, 1996

Fujisawa claims fibrinogen antagonists

Nov. 8, 1996

Canadian researchers claim hirudin derivative

Nov. 8, 1996

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...